Affiliation:
1. Department of Biotechnology, Sri Ramachandra Institute of Higher Education and Research (DU), Porur, Chennai
600116, Tamil Nadu, India
2. Wellcome Trust Research Laboratory, Division of Gastrointestional Sciences, Christian
Medical College and Hospital, Vellore 632004, Tamil Nadu, India
Abstract
Background & Objective:
Candida albicans (C.-P. Robin) Berkhout, the pathogenic
yeasts’ ability to transform from yeast to hyphal forms in the bloodstream is essential during systemic
infections. Among the several virulence factors studied, secreted aspartic proteinases (SAPs)
involved in hyphal penetration are targets of putative hyphal inhibitors. Upregulation of SAP6
gene, (two-to 31- fold high) during budded to hyphal transition and lack of studies on its inhibition,
prompted us to investigate this particular protein using in silico tools.
Results:
Hyphal inhibition of germinating yeast cells by melianone, a triterpenoid, from Swietenia
mahagoni (L.) Jacq. (Meliaceae) was observed at 0.1 μM (IC50). One of the targets of putative hyphal
inhibitors, SAP, was assayed and for the first time, 50 % of the biological SAP activity was
found to be inhibited by melianone at 0.125 μM. This data on SAP inhibition led us to analyse the
3-dimensional structure for SAP6 protein that was constructed through a combination of homology
modelling and ab-initio method (Phyre2) and validated before performing Induced Fit Docking
(IFD). Melianone formed H-bond and hydrophobic interactions with the crucial residues (ASP108,
TYR160, ALA161, ASP162, ASP294, THR297, ASP379) in the catalytic site of SAP6 with a glide
energy (-)54.9327 kcal/mol upon Induced Fit Docking (IFD).
Conclusion:
We report here for the first time on the SAP inhibitory ability of melianone at 0.125
uM. Being a small molecular mass inhibitor, binding with high affinity to the S3 pocket sites of
SAP proteins provides evidence for pre-clinical testing of such compounds against fungal pathogens.
The study is a valuable insight for further research on novel and effective inhibitors targeting
SAP.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Molecular Medicine,General Medicine
Reference39 articles.
1. Regional Office for South-East Asia. Laboratory manual for diagnosis of fungal opportunistic infections in HIV/AIDS patients. WHO Regional Office for South-East Asia World Health OrganizationAvailable from: 2009
2. Toenjes K.A.; Stark B.C.; Brooks K.M.; Johnson D.I.; Inhibitors of cellular signalling are cytotoxic or block the budded-to-hyphal transition in the pathogenic yeast Candida albicans. J Med Microbiol 2009,58(Pt 6),779-790
3. Yang W.; Chen X.; Li Y.; Guo S.; Wang Z.; Yu X.; Advances in pharmacological activities of terpenoids. Nat Prod Commun 2020,15(3),1-13
4. Zhang T.; Zhong S.; Li T.; Zhang J.; Saponins as modulators of nuclear receptors. Crit Rev Food Sci Nutr 2020,60(1),94-107
5. Raut J.S.; Shinde R.B.; Chauhan N.M.; Karuppayil S.M.; Terpenoids of plant origin inhibit morphogenesis, adhesion, and biofilm formation by Candida albicans. Biofouling 2013,29(1),87-96
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献